Jul 13, 2018
Each quarter, Locust Walk deal team members compile compile key statistics and performance indicators on the latest Medtech transactions. Our Q2 2018 Trends in Medtech Transactions report applies the latest data to analyze current activities in the life science deal...
Jul 13, 2018
Locust Walk is a global life science transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done...
Apr 11, 2018
Locust Walk is a global transaction firm serving biopharma and medtech companies in the US, Europe, and Asia. Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Q1 2018 Trends in...
Apr 11, 2018
Locust Walk is a global transaction firm serving biopharma and medtech companies in the US, Europe, and Asia. Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Q1 2018 Trends in Medtech...
Oct 11, 2017
Each quarter Locust Walk experts compile key statistics and trends on strategic transactions and financings. Our Q3 report uses the latest data to analyze current trends in the life science deal landscape. In this report you can find an overview and analysis of:...
Jul 6, 2017
Our Q2 report analyzes current trends of 2017, and how life science strategic deal activity has been performing in recent years. In this report you can find an overview and analysis of: Biopharma public indices Biopharma IPOs Deal activity for strategic partnership...
